Deferoxamine

Fresenius Kabi USA, LLC🇺🇸 United States

FDA Page

Effective Date: Jun 15, 2026
Approval ID: d91e16df-8daa-4cd2-86a2-273eaa2446e0
Products: 2 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DEFEROXAMINE MESYLATE FOR INJECTION safely and effectively. See full prescribing information for DEFEROXAMINE MESYLATE FOR INJECTION. DEFEROXAMINE MESYLATE for Injection, for intramuscular, intravenous, or subcutaneous useInitial U.S. Approval: 1968

Quick Stats

Total Products2

Labelers2

Label Sections13

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.